Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Berman, R. M. et al. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351–354 (2000)
Zanos, P. et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533, 481–486 (2016)
Autry, A. E. et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475, 91–95 (2011)
Nosyreva, E. et al. Acute suppression of spontaneous neurotransmission drives synaptic potentiation. J. Neurosci. 33, 6990–7002 (2013)
Nosyreva, E., Autry, A. E., Kavalali, E. T. & Monteggia, L. M. Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade. Front. Mol. Neurosci. 7, 94 (2014)
Atasoy, D. et al. Spontaneous and evoked glutamate release activates two populations of NMDA receptors with limited overlap. J. Neurosci. 28, 10151–10166 (2008)
Gideons, E. S., Kavalali, E. T. & Monteggia, L. M. Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses. Proc. Natl Acad. Sci. USA 111, 8649–8654 (2014)
Lukas, G., Brindle, S. D. & Greengard, P. The route of absorption of intraperitoneally administered compounds. J. Pharmacol. Exp. Ther. 178, 562–564 (1971)
Collingridge, G.L. et al. Antidepressant actions of ketamine versus hydroxynorketamine. Biol. Psychiatry 81, e65–e67 (2016)
Zanos, P. et al. Reply to: antidepressant actions of ketamine versus hydroxynorketamine. Biol. Psychiatry 81, e69–e71 (2016)
Singh, J. B. et al. Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study. Biol. Psychiatry 80, 424–431 (2016)
Moaddel, R. et al. Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors. Eur. J. Pharmacol. 698, 228–234 (2013)
Kotermanski, S. E., Wood, J. T. & Johnson, J. W. Memantine binding to a superficial site on NMDA receptors contributes to partial trapping. J. Physiol. (Lond.) 587, 4589–4604 (2009)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
This file contains Supplementary Methods. (PDF 94 kb)
PowerPoint slides
Rights and permissions
About this article
Cite this article
Suzuki, K., Nosyreva, E., Hunt, K. et al. Effects of a ketamine metabolite on synaptic NMDAR function. Nature 546, E1–E3 (2017). https://doi.org/10.1038/nature22084
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/nature22084
This article is cited by
-
In silico investigation of ketamine and methylphenidate drug-drug conjugate for MDD and ADHD treatment using MD simulations and MMGBSA
Scientific Reports (2025)
-
Spatiotemporal terahertz modulation enhances NMDAR-mediated miniature EPSCs
Scientific Reports (2025)
-
Rapid hippocampal synaptic potentiation induced by ketamine metabolite (2R,6R)-hydroxynorketamine persistently primes synaptic plasticity
Neuropsychopharmacology (2025)
-
Synaptic basis of rapid antidepressant action
European Archives of Psychiatry and Clinical Neuroscience (2025)
-
Ketamine impairs growth cone and synaptogenesis in human GABAergic projection neurons via GSK-3β and HDAC6 signaling
Molecular Psychiatry (2024)